CAS 61825-94-3
:Oxaliplatin
- Oxalato(trans-(-)-1,2-cyclohexanediamine)platinum(II)
- Platinum, [(1R,2R)-1,2-cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]-, (SP-4-2)-
- platinum(2+) ethanedioate (1R,2R)-cyclohexane-1,2-diamine (1:1)
- NSC-266046
- [SP-4-2-(IR-trans)]-(1,2-cyclohexanediamine-n,n')[ethanedioato(2-)-O,O']-platinum
- (1R,2R)-cyclohexane-1,2-diamine: oxalic acid: platinum(+2) cation
- xalatoplatinum
- (SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]platinum
- Platinum, [(1R,2R)-1,2-cyclohexanediamine-κN,κN′][ethanedioato(2-)-κO1,κO2]-, (SP-4-2)-
- latin
- cyclohexane-1,2-diamine: oxalic acid: platinum
- RP-54780
- (sp-4-2)-((1r,2r)-1,2-cyclohexanediamine-n,n')(ethanedioato(2-)-O,O']platinum
- Platinum, (1,2-cyclohexanediamine-N,N′)[ethanedioato(2-)-O,O′]-, [SP-4-2-(1R-trans)]-
- platinum(4+) cyclohexane-1,2-diyldiazanide ethanedioate (1:1:1)
- Elocatin
- Oxalipatin
- trans-L-Diaminocyclohexane oxalatoplatinum
- 1,2-Cyclohexanediamine, platinum complex, (1R-trans)-
- ι-OHP
- [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,N,)[ethanedioato(2-)-O,O’Jplatinum
- OXALIPLATIN
- OXALIPIATIN
- Lipoxal
- SP-4-2-(1R-TRANS)]-(1,2-CYCLOHEXANEDIAMINE-N,N)[ETHANEDIOATO(2-)-O,OPT
- Oxaliplatin(Eloxatin)
- NSC-266046:Elocatin
- Eloxatin
- Cis-[(1R,2R)-1,2-cyclothexanediammine-N,N`][oxalato(2-)-O,O`]platinum
- Oxalato[(1R-trans)-1,2-cyclohexanediamine]platinum(II)
- P-54780
- oxalatoplatinum
- [SP-4-2-(1R-TRANS)]-(1,2-CYCLOHEXANEDIAMINE-N,N')[ETHANEDIOATA(2-)-O,O']PLATINUM
- oxaliplatino
- Oxaliplatin (125 mg)
- platinuM(2+) ion (1R,2R)-cyclohexane-1,2-diaMine oxalate
- oxalatoplatin
- Oxaliplatin EP/BP
- (1R-trans)-1,2-Cyclohexanediamine, platinum complex
- [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,N
- 1-ohp
- (1,2-cyclohexanediamine-n,n’)(ethanedioato(2-)-o,o’)-platinu(sp-4-2-(1r-tr
- OxaliplatinEp5
- Dacplat
- Elplat
- OXALIPLATIN (oxaliplatin)
- oxalato(1r,2r-cyclohexanediammine)platinum(ii)
- [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,Nˊ)[ethanedioato(2-)-O,Oˊ]platinum
- (trans-1,2-Cyclohexanediamine)oxalatoplatinum(II)
- Oxaliplatin99%
- Oxaliplatin API
- Weitere Synonyme anzeigen
Oxaliplatin
CAS:Formel:C8H14N2O4PtFarbe und Form:White to Almost white powder to crystalMolekulargewicht:397.29Oxaliplatin
CAS:Inorganic or organic compounds of precious metals, whether or not chemically defined, or amalgams of precious metals, nesoiFormel:C8H14N2O4PtFarbe und Form:White Off-White PowderMolekulargewicht:397.06015Trans-L-Diaminocyclohexane Oxalatoplatinum
CAS:Formel:C8H14N2O4PtReinheit:98%Farbe und Form:SolidMolekulargewicht:397.2858Oxaliplatin
CAS:Oxaliplatin (L-OHP) is a DNA alkylating agent, an inhibitor of DNA synthesis.Formel:C8H14N2O4PtReinheit:97% - 99.93%Farbe und Form:SolidMolekulargewicht:397.29Oxaliplatin
CAS:Formel:C8H14N2O4PtReinheit:98.0 - 102.0 % (dried basis)Farbe und Form:White to almost white crystalline powderMolekulargewicht:397.29Oxaliplatin
CAS:OxaliplatinFormel:C8H14N2O4PtReinheit:98%Farbe und Form: white solidMolekulargewicht:397.29g/molOxaliplatin
CAS:Kontrolliertes ProduktFormel:C8H14N2O4PtFarbe und Form:White To Off-WhiteMolekulargewicht:397.29Oxaliplatin
CAS:Kontrolliertes ProduktApplications Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.
References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),Formel:C8H14N2O4PtFarbe und Form:White To Off-WhiteMolekulargewicht:397.29Oxaliplatin - Bio-X ™
CAS:Oxaliplatin is a platinum-based DNA-cross-linking agent. It is a chemotherapeutic drug, often used in combination with leucovorin, fluorouracil, and capecitabine. Oxaliplatin works by cross-linking DNA thus inhibiting the synthesis of RNA and proteins, which leads to cell death and inhibition of cancer cells growth. It is more effective than cisplatin or irinotecan in treating metastatic cancer. Oxaliplatin also has effects on Toll-like receptor 4 (TLR4) expression levels in vitro and in vivo models. In addition, oxaliplatin's effect on ATP binding cassette transporter proteins may be responsible for its antitumour activity against solid tumours.
Oxaliplatin is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.Formel:C8H14N2O4PtReinheit:Min. 98 Area-%Farbe und Form:White PowderMolekulargewicht:397.29 g/molOxaliplatin
CAS:Oxaliplatin is a platinum-based DNA-cross-linking agent. It is a chemotherapeutic drug, often used in combination with leucovorin, fluorouracil, and capecitabine. Oxaliplatin works by cross-linking DNA thus inhibiting the synthesis of RNA and proteins, which leads to cell death and inhibition of cancer cells growth. It is more effective than cisplatin or irinotecan in treating metastatic cancer. Oxaliplatin also has effects on Toll-like receptor 4 (TLR4) expression levels in vitro and in vivo models. In addition, oxaliplatin's effect on ATP binding cassette transporter proteins may be responsible for its antitumour activity against solid tumours.Formel:C8H14N2O4PtReinheit:Min. 98 Area-%Farbe und Form:White Off-White PowderMolekulargewicht:397.29 g/mol













